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ABBREVIATIONS
α              alpha
β              beta
bp             base pairs
DNA        deoxyribonucleic acid
dATP       2’-deoxyadenosine 5’-triphosphate
dCTP       2’-deoxycytidine 5’-triphosphate
dTTP       2’deoxythymidine-5’-triphosphate
dGTP       2’deoxyguanosine-5’-Triphosphate
EtBr         Ethidium bromide
EDTA      Ethylene Diamine Tetra Acetate
gDNA      genomic Deoxyribonucleic acid
HCl           Hydrochloric acid
KCl           Potassium chloride
Kb            Kilo base
Kbp          Kilo base pair
ml             Milliliter
µM           Micro mole
µg             Microgram
µl              Micro litre
mM           Milli mole
MgCl2          Magnesium chloride
MgSo4      Magnesium sulphate
NaCl         Sodium chloride
ng             Nano gram
PCR         Polymerase chain reaction
rpm          Revolutions per minute
RFLP       Restriction Fragment Length Polymorphism
RAPD      Random Amplification of Polymorphic DNA
RNA        Ribonucleic acid
RE           Restriction enzyme or Restriction endonucleases
            STR         Short Tandem Repeats
SNP        Single Nucleotide Polymorphism
SDS        Sodium Dodecyl  sulphate
Taq         Thermus aquaticus
TE          Tris Ethylene diamine tetraacetate
TBE       Tris borate
TAE       Tris acetate and EthyleneDiamineTetraAcetate
TPE        Tris Phosphate
%            Percentage
1. INTRODUCTION
Deoxyribonuclei  acid  (DNA)  is  a  molecule  present  in  all  living  things, 
including bacteria, plants, and animals.  DNA is the information encoded in genetic 
material in other words it carries genetic information that is inherited or passed down 
from parents to offspring.  It is responsible for determining a person’s hair, eye and 
skin color, facial features, complexion, height, blood type, and just about everything 
else  that  makes  an  individual  unique.   DNA  is  responsible  for  establishing  and 
maintaining the cellular and biochemical function of an organism1.   DNA synthesis is 
called replication2.
1. STRUCTURE OF DNA3
DNA is a double helix, with bases to the center (like rungs on a ladder) and 
sugar-phosphate units along the sides of the helix (like the sides of a twisted ladder). 
DNA  is  a  polymer  and  stores  biological  information  digitally  in  units  called 
nucleotides and these specify which proteins an organism will make, as well as when 
and where protein synthesis  will  occur.  Each nucleotide consists  of a deoxyribose 
sugar,  a  phosphate  and  a  nitrogenous  base.   The  strands  are  complementary  as 
deduced by Watson and Crick from Chargaff’s data, A pairs with T and C pairs with 
G, the pairs held together by hydrogen bonds.  Double ringed purine is always bonded 
to a single ring pyrimidine.  Purines are Adenine (A) and Guanine (G).  Pyrimidines 
are Cytosine (C) and Thymine (T).  In DNA the sugar is deoxyribose. The bases are 
complementary, with A on one side of the molecule the other side is T and similarly 
with G and C4.  The DNA regions which encode proteins are called genes.  
Figure  1.  STRUCTURE OF DNA
1.1 LOCATION OF DNA
Within  cells  of  an  organism,  DNA  molecules  are  assembled  into 
chromosomes,  organelles  that  package  and  manage  the  storage,  duplication, 
expression and evolution of DNA.  In the chromosomes of a cell, DNA occurs as fine 
spirally  coiled  threads,  that  in  turn coils  around another,  like  a  ladder.   The total 
length of all DNA in the Cell’s nucleus would be 3km.    The entire collection of 
chromosomes in each cell  of an organism is its genome5.  Human cells contain 23 
distinct kinds of chromosomes carrying approximately 3×109 base pairs and roughly 
100,000 genes.  The structure of the DNA helix is preserved by weak interactions (i.e. 
hydrogen bonds and hydrophobic interactions established between the stacked base), 
it is possible to separate the two strands by treatments involving heating, bringing to 
alkaline pH6.
Figure 2: Location of DNA
 As the Human Genome Project provides the foundation for understanding the 
genetic basis of common disease (1) population based genetic studies will provide the 
information needed for the practical application of genetic risk factors to chemical and 
public health practice.  To this end, researchers have begun collecting specimens for 
molecular analyses in epidemiologic studies and surveys in order to identify genetic 
risk factors for disease (2) Genomic markers including RFLP, STR, insertion-deletion 
polymorphism, SNP and groups of markers inherited together on one chromosome as 
haplotypes and being used to locate disease associated genetic loci and studies of the 
association between these loci to disease are elucidating the genetic basis for disease. 
Once  risk  associated  genotypes  are  identified  the  validity  of  genetic  testing  for 
screening  and  clinical  practice  must  be  assessed7.   Interest  in  genome-wide 
association studies to identify susceptibility alleles for cancer is growing, and several 
are currently planned or under way. A critical requirement for such large scale studies 
is the amount of DNA available from a sample.   Traditionally whole blood is the 
tissue of choice, as the yield of DNA is quite high (typically 10-15μg/ml).  However 
obtaining  a  blood  sample  is  an  invasive  procedure  that  requires  training  in 
phlebotomy,  and moreover blood samples require refrigerated storage and must be 
processed within a week or so of collection.  These constraints limit the suitability of 
blood collection for some populations which in turn has led to a search for alternative 
sources of DNA.  The ideal source should meet the following requirements (1) be 
non-invasive easy and quick to carry out (2) allow relatively long storage of samples 
at ambient temperatures before DNA extraction ( a critical required for field studies) 
with minimal loss of DNA quality and finally (3)   yield a sufficiently large amount of 
DNA for a wide variety of applications. Alternatives that have been investigated to 
date, includes dried blood spots, plucked hairs and cheek swabs.  However the yield 
of DNA is much less than these alternatives  than with whole blood, cheek swabs 
constitute the highest yielding noninvasive alternative to whole blood as cheek swabs 
provide  app  5-15μg  of  DNA8.   Although  the  feasibility  of  collecting  buccal  cell 
samples as an alternative to venous blood samples as a source of genomic DNA has 
been shown, the validity of using DNA from buccal cells for genome wide scans has 
not been assessed9.  
Different sample types used in DNA extractions include10 
Whole  blood,  Buffy  coats,  Blood  clots,  Serum,  Plasma,  Cell  pellets, 
Mouthwash, Buccal swabs,  Cytobrushes,  Saliva,  Bronchial  alveolar  lavage,  Mouse 
tails, Plants.
Other  solid  tissues  that  can  be  used  for  DNA  extraction  include  Breast, 
Prostrate, Kidney, Brain, Placental, Heart, Muscle.
Other sample types include Nails, Paraffin embedded tissue, Polyps, Urine, Feces 
and sputum. These sample types create great difficulty in isolating DNA.
Normally DNA can be extracted by three methods
1) Non-organic
2) Column Based
3) Organic.
Obtaining high quality genomic DNA is critical for epidemiological studies 
that aim to evaluate the role of genetic factors in human disease susceptibility.  Blood 
samples  are  an  excellent  source  of  large  amounts  of  genomic  DNA.   However, 
epidemiological  studies  often  need  alternative  sources  when  study  subjects  are 
reluctant to provide a blood sample, when only a self-administered collection protocol 
is logistically or economically feasible or as backup source of DNA in studies that 
collect blood samples11.
1.2. BUCCAL CELLS:
Buccal cells are the cells from the inner lining of the mouth, or cheek.  These 
cells  are  routinely  shed  and  replaced  by  new  cells.   As  the  old  cells  die,  they 
accumulate  in the saliva in the mouth and can be easily be collected by a simple 
procedure using mouthwash12.  The mean number of epithelial cells per 1ml of saliva 
is about 4.3x105,  whereas the number of nucleated cells  in 1ml of whole blood is 
about  4.5-11x105.   Moreover  the  turnover  of  epithelial  cells  is  quite  extensive  in 
mouth,  as  the  surface  layer  of  epithelial  cells  is  replaced  on  average  every  2.7h 
suggesting that there is likely to be intact gDNA in saliva samples8.
1.2.1 ADVANTAGES OF BUCCAL CELLS:
Collecting buccal cells enables researchers to better understand the way people 
process substances that affect cancer and other diseases and to determine why some 
people  who  are  exposed  to  certain  substances  develop  diseases,  whereas  others 
exposed to the same substances  do not.   The material  in the buccal  cell  samples, 
combined  with  information  on  occupational,  environmental,  and  dietary  factors, 
allows researchers to get a more complete assessment of what is affecting the health 
of  human  population.  The  buccal  cell  sample  is  being  collected  to  study  the 
differences  in  genes  that  may  be  related  to  how  people  process  disease-causing 
substances and how the effects of diet, lifestyle, environment, race and ethnicity, age, 
and other factors may be related to these genes.
1.2.2 CHARACTERISTICS OF BUCCAL CELLS
1. Research has shown that sublingual cells correlate well with deep body tissue 
such as heart tissue taken during bypass surgery and skeletal muscle biopsies.
2. Buccal  cells  have  high  correlation  between  altered  mineral  levels  and  path 
physiological conditions in multiple medical syndromes.
3. Sublingual  cells  provide  new  and  important  information  as  to  the  status  of 
cardiac mineral electrolytes in patients with cardiovascular disease.
4. Sublingual epithelial cells offer a rapidly renewing, homogenous cell population 
that reflects current total body intracellular mineral status.
5. Buccal  cells  have  a  high  cytoplasm  to  nucleus  structure  facilitating  mineral 
analysis.  Cells contain full metabolic biochemical pathways.
6. Blood and urine levels of minerals and ions do not necessarily reflect what is 
happening in the working cellular tissues.
7. Cells contain about 99% of the body’s magnesium and potassium, while serum 
contains only 1% of the total.
8. Low intracellular tissue levels of mineral electrolytes may exist wile the serum 
levels appear normal.  
9. Buccal cells are safe, easy to obtain and use as a smear on specially prepared 
slides.             
      Fixed specimens have a long life and do not deteriorate in transit13. 
Genomic DNA is identical whether it comes from blood cells or cheek cells. 
Buccal cell is viable alternative to isolation from blood.  Buccal cell DNA is used for 
many diagnostic  applications such as epidemiologic studies and paternity testing14. 
There  are  several  advantages  to  buccal  cell  DNA isolation  over  blood.   First  no 
needles, are involved, so it is less invasive and painless.   It is well suited for young 
subjects.  Buccal cells provide less of a potential hazard to the people who handle 
samples15.
Repeated sampling is not always feasible by blood.  With the growing interest 
in large scale genomic studies epidemiological studies have become very important in 
trying to elucidate gene-environment interaction in individuals prone to multigenic 
diseases like cancer and cardiovascular diseases.  As already known exfoliated buccal 
cells are a good source of DNA and sample collection in such cases is non-invasive 
and can be self-administered. The average yield is about 30µg and is sufficient for 
more  than  300 PCR amplifications.   It  has  been observed that  good quality  high 
molecular weight genomic DNA can be obtained from exfoliated buccal cells in the 
early  morning  mouthwash  samples  and that  the  DNA yield  from similar  samples 
decreases during the day, with very low yields obtained in the late evening.  This was 
due to very few exfoliated cells being present in the oral cavity at the time 16.  Oral 
epithelial cells are constantly exfoliated and may be captured through gentle scraping 
of the oral mucosa or by oral rinsing17.
One published study reported  the  quantity,  quality,  and stability  of  hDNA 
collected with mouthwash.  Specimens yielded a median quantity of at least 32µg 
DNA (2-94) if specimens were held for up to 5 days, with yields declining to 21µg (5-
56) at 30 days.  Polymerase chain reaction success rates were greater than 94% and 
high molecular weight DNA (>23kb) was found in all but 1 out of 24 specimens. 
Yields  were  greater  when  specimens  were  collected  before  brushing  teeth7.  Self 
Collection of oral  epithelial  cells  at  a subject’s home or hospital  under instruction 
from medically trained or untrained personnel is an attractive and efficient approach 
for  many  epidemiologic  studies18.   Methods  for  collecting  buccal  epithelial  cells 
include  cotton  swabs,  cytology  brushes,  wooden  sticks,  and  mouthwashes,  with 
mouthwashes  giving  greater  yields.  Several  mouthwashes  have  been  tested  3% 
sucrose, 5% glucose, saline, water and commercial mouthwash.  In addition, clinical 
validation  studies  have  shown  that  DNA  diagnostic  results  from patient-matched 
buccal cells and whole blood are comparable. At least 2 main approaches to DNA 
purification have been used with mouthwash specimens; (1) a rapid boiling method, 
yielding low-quality DNA, and (2) a lengthy phenol-chloroform method using toxic 
reagents19.  
Method of 
collection
Median Range SD
Blood 95 10-283 54
Mouthwash 11 4-78 13
Buccal cytobrush 8 4-39 7
                        (Table 1).  According to Neuhas20Total DNA yields (μg) for each 
sampling method and Standard Deviation is shown. 
Specimen 
type
DNA yield Advantages Disadvantages
Blood spots 12-42  ng/μl 
(adults)
43-78  ng/μl 
(neonates)
Small sample size
Ease of collection
Low cost storage
Offers  a  source  for  study  of 
exogenous  or  endogenous 
compounds other than DNA
Genotyping  generally  requires 
10  ng/genotype  and  with 
current  technology as llittle  as 
2.5 ng per SNP so that scores to 
hundreds of genotypes could be 
obtained from one blood spot
Low  DNA  yield  may 
not  be  suitable  for 
whole-genome 
amplification.
Non renewable
Smaller amplicons
Blood cells
Whole  blood 
anticoagulated 
or blood clots
Buffy coat
100-400 
μg/10ml
200 μg/ml
Relatively low-cost storage
Yields large quantities of  high 
quality of genomic DNA
Offers  a  source  for  study  of 
exogenous  or  endogenous 
compounds other than DNA
Invasive  sample 
collection
Non renewable
Transformed 
lymphocytes
106cells = 6 μg Renewable source of DNA
Yields large quantities of High-
quality genomic DNA
Labor-intensive 
preparation
High cost storage
Does not offer a source 
for study of exogenous 
or  endogenous 
compounds  other  than 
DNA or RNA
Buccal cells 49.7  μg  mean; 
0.2-134  μg 
range  (total 
mouthwash 
DNA)
1-2 
μg/cytobrush 
and swab.
32  μg  median; 
4-196 μg range 
human DNA in 
mouthwash 
Noninvasive  and  easy  sample 
collection.  Genotyping 
generally  requires  10 
ng/genotype  and  with  current 
technology as  llittle  as  2.5  ng 
per  SNP  for  genotyping  for 
getting  more  genotypes  from 
buccal cell specimen.
Low DNA yield.
Highly variable yield.
Does not offer a source 
for study of exogenous 
or  endogenous 
compounds  other  than 
DNA or RNA.
Bacterial 
contamination must be 
addressed.
(Table 2) : Comparison of Specimens for DNA Banking for Epidemiologic studies
1.3. MUTATION1
Mutations are heritable changes in base sequences that modify the information 
content of DNA and can alter the amino acid sequence of the protein encoded by the 
gene.
1.3.1 Forward mutation:
A mutation that changes the wild type allele of a gene to a different allele is 
called a forward mutation.
1.3.2 Reverse mutation or reversion:
Mutation can also cause a novel mutant allele to revert back to wild type.
1.3.3 Substitution:
   This  occurs  when  a  base  at  a  certain  position  in  one  strand  of  the  DNA 
molecule is replaced by one of the other three bases.  During DNA replication a base 
substitution  in  one  strand  will  cause  a  new  base  pair  to  appear  in  the  daughter 
molecule generated from that strand.  There are two types
i) Transition:  In  this  a  purine  replaces  the  other  purine  or  one 
pyrimidine replaces the other.
ii) Transversion:  Purine replaces a pyrimidine or vice versa.
1.3.4 Deletion:
Occurs when a block of one or more nucleotide pairs  is lost  from a DNA 
molecule.
1.3.5 Insertion:
The addition of one or more nucleotide pairs.
1.3.6 Others:  
Hydrolysis, Radiation UV and Oxidation can alter the information stored in 
DNA.
1.3.7 Depurination:
       The hydrolysis of a purine base A or G from the deoxyribose phosphate back 
bone occurs 1000times an hour in every human cell.  Because the resulting apurinic 
sites cannot specify a complementary base the DNA replication process sometimes 
introduces a random base opposite the apurinic site causing a mutation in the newly 
synthesized complemetary strand 3 quarter of the time.
1.3.8 Deamination:
The removal of an amino group can change cytosine to uracil, the nitrogenous 
base found in RNA but not in DNA, and already known U always pairs with A rather 
than G deamination follwed by replication may alter a  C-G base to T-A pair in future 
generation of DNA molecules5.  Damaged DNA could mean the failure of important 
cell processes, or could even lead to cancer and early death21.
1.4. DNA Repair mechanisms
The following structural changes occur in DNA during mutation:
• Pyrimidine dimers, in which two adjacent pyrimidines on a DNA strand are 
coupled by additional covalent bonds and thus lose their ability to pair.
• Chemical changes of single bases, such as alkylation or deamination, thus 
causing changes in the pairing properties of the DNA.
• Crosslinks between the complementary DNA strands,  which prevent  their 
separation in replication.
•  Intercalation  of  mutagenic  agents  into  the  DNA  causing  frameshift 
mutations.
• Single strand breaks.
• Double strand breaks22.
DNA repair refers to a collection of processes by which a cell identifies and 
corrects damage to the DNA molecules that encode its genome. In human cells, both 
normal metabolic  activities and environmental factors such as UV light can cause 
DNA damage, resulting in as many as 1 million individual molecular lesions per cell 
per day. Many of these lesions cause structural damage to the DNA molecule and can 
alter  or  eliminate  the  cell's  ability  to  transcribe  the  gene  that  the  affected  DNA 
encodes.  Other  lesions  induce  potentially  harmful  mutations  in  the  cell's  genome, 
which  affect  the  survival  of  its  daughter  cells  after  it  undergoes  mitosis. 
Consequently,  the DNA repair process must be constantly active so it can respond 
rapidly to any damage in the DNA structure. The rate of DNA repair is dependent on 
many  factors,  including  the  cell  type,  the  age  of  the  cell  and  the  extracellular 
environment. A cell that has accumulated a large amount of DNA damage, or one that 
no longer  effectively repairs  damage incurred to  its  DNA, can enter  one of three 
possible states:
• an irreversible state of dormancy, known as senescence
• cell suicide, also known as apoptosis or programmed cell death 
• unregulated cell division, which can lead to the formation of a tumor 
that is cancer.
1.4.1 DNA REPAIR AND CANCER:
Inherited mutations that affect DNA repair genes are strongly associated with 
high cancer risks in humans. Hereditary nonpolyposis colorectal cancer (HNPCC) is 
strongly associated  with specific  mutations  in  the DNA mismatch  repair  pathway. 
BRCA1 and BRCA2, two famous mutations conferring a hugely increased risk of 
breast  cancer  on carriers,  are both associated with a large number of DNA repair 
pathways,  especially  NHEJ  and  homologous  recombination.  Cancer  therapy 
procedures  such  as  chemotherapy  and  radiotherapy  work  by  overwhelming  the 
capacity of the cell to repair DNA damage, resulting in cell death. Cells that are most 
rapidly dividing - most typically cancer cells - are preferentially affected. The side 
effect is that other non-cancerous but rapidly dividing cells such as stem cells in the 
bone marrow are also affected. Modern cancer treatments attempt to localize the DNA 
damage to cells  and tissues only associated with cancer,  either  by physical  means 
(concentrating the therapeutic agent in the region of the tumor) or by biochemical 
means (exploiting a feature unique to cancer cells in the body)23. ....,...
Worldwide, tobacco kills one human being every six seconds.
• That works out to 560 people every hour, 13,440 people per day and 49 lakh 
people per annum.
• Tobacco kills 15 times as many people as suicides, murder or manslaughter45 
1.4.2 TOBACCO CHEWING AND SMOKING:
Smoking and tobacco chewing is probably the most obvious factor for adverse 
mortality and is perhaps less obvious is that smoking inflicts extensive DNA damage. 
Tobacco smoke contains over two hundred chemicals known to cause cancer, known 
as carcinogens.  The precise mechanism whereby cancer starts is not fully understood. 
These  DNA  mutations  are  permanent  and  forever  increase  the  likelihood  for 
developing lung cancer.  Tobacco smoke also contains chemicals in a group called the 
polycyclic aromatic hydrocarbons which can lead to specific genetic mutations in a 
gene  known as  ‘p53’.   ‘p53’  plays  an important  role  in  suppressing tumours  and 
significantly,  mutations in this gene are present in around half of all major human 
tumours24.  Tobacco smoking is the most important and well documented cause of 
cancer  currently  known.   Epidemiological  associations  have  been  found for  lung, 
mouth,  pharynx,  oesophagus,  kidney,  bladder,  pancreas  and  cervix  cancer.   The 
relationship  with  cancer  of  the  mouth,  pharynx,  oesophagus  and  lung  is  easily 
explained by their direct contact with smoke.  In the light of the fact that over 90% 
cancers  involve  epithelial  cells  and  that  DNA  damage  is  considered  a  crucial 
mechanism  in  cancer  development,  the  evaluation  of  DNA  damage  in  buccal 
epithelial cells may thus provide a good biomarker of early damage in target tissues21. 
Single gene errors account for more than 4,000 known hereditable diseases, and the 
list  is  growing  rapidly.   A  person’s  risk  for  diseases  from  cystic  fibrosis  to 
Huntington’s disease now can be determined by looking at the DNA.
Given  the  emphasis  on  the  role  of  genetics  in  cancer  development  and 
prevention, simple and cost-effective methods are needed to obtain DNA for large-
scale studies.  The methods for buccal cells are of two types: dry procedures that use a 
cytobrush or other implements for scraping of the oral mucosa, and wet procedures 
that involve swishing liquids in the mouth and spitting into a collection vessel.  The 
advantages of the swish method appear to be higher average DNA yields, longer DNA 
fragments, and possibly higher percentages of human DNA25.
Studies suggest that buccal cell samples remain stable at room temperature for 
up to 2 weeks before DNA extraction and they can be successfully analyzed even 
after exposure to warm or cold temperatures for 7 days.  However evidence from a 
study of mouthwash collections suggests that samples should be extracted within 5 
days, if possible, to maximize human DNA yields.  Extracted DNA samples can be 
preserved for several years when store at -20oC.
Among adults studies suggest that mouthwash collections provide buccal cell 
DNA of higher quantity and purity than cytobrushes, with the alcohol content serving 
as a preservative to retard the growth of bacterial and fungal contaminants.  However 
mouthwash  collection  is  not  an  option  for  infants  or  toddlers  or  for  adults  from 
societies unaccustomed to its use26.
1.5. AGAROSE GEL ELECTROPHORESIS
Agarose is a linear polymer composed of alternating residues of D- and L- 
galactose joined by alpha- (1-3) and beta-(1-4) glycosidic linkages.  The L-galactose 
residue has an anhydro bridge between the three and six positions.
Figure 3: Structure of Agarose
Chains of agarose form helical fibers that aggregate into supercoiled structures 
with a radius of 20-30nm.  Gelation of agarose results in a three-dimensional mesh of 
channels whose diameters range from 50nm to 200nm.  
1.5.1 THE RATE OF MIGRATION OF DNA THROUGH AGAROSE GELS
The following factors determine the rate of migration of DNA through agarose gels
(i) The molecular size of the DNA:
Molecules of double-stranded DNA migrate through gel matrices at rates that 
are inversely proportional to the log10 of the number of base pairs.  Larger molecules 
migrate more slowly because of greater frictional drag and because they worm their 
way through the pores of the gel less efficiently than smaller molecules.
(ii) The concentration of agarose:
A linear DNA fragment of a given size migrates at different rates through gels 
containing different concentrations of agarose.  There is a linear relationship between 
the logarithm of the electrophoretic mobililty of the DNA and the gel concentration. 
(iii) The conformation of the DNA:
Superhelical circular (form I), nicked circular (form II), and linear (form III) 
DNAs migrate through agarose gels at different rates.  The relative mobilities of the 
three forms depend primarily on the concentration and type of agarose used to make 
the gel, but they are also influenced by the strength of the applied current, the ionic 
strength  of  the buffer,  and the  density  of  superhelical  twists  in  the form I  DNA. 
Under some conditions, form I DNA migrates faster than form III DNA; under other 
conditions, the order is reversed.  In most cases, the best way to distinguish between 
the different conformational forms of DNA is simply to include in the gel a sample of 
untreated circular DNA and a sample of the same DNA that has been linearized by 
digestion with a restriction enzyme that cleaves the DNA in only one place.
(iv) The presence of ethidium bromide in the gel and electrophoresis buffer:
Intercalation of ethidium bromide causes a decrease in the negative charge of 
the double stranded DNA and an increase in both its stiffness and length.  The rate of 
migration of the linear DNA dye complex through gels is consequently retarded by a 
factor  approximately  15%.   The  most  convenient  and commonly  used  method  to 
visualize DNA in agarose gels is stainig with the flouresent dye ethidium bromide 
which contains a tricyclic planar group that intercalates between the stacked bases of 
DNA.  Ethidium bromide binds to DNA with little or no sequence preference.  At 
saturation in solutions of high ionic strength, approximately one ethidium molecule is 
intercalated per 2.5 bp.  After insertion into the helix, the dye lies perpendicular to the 
helical axis and makes van der Waals contacts with the base pairs above and below. 
The fixed position of the planar group and its close proximity to the bases cause dye 
bound to DNA to display an increased fluorescent yield compared to that of dye in 
free solution.  UV radiation at 254nm is absorbed by the DNA and transmitted to the 
dye radiation at 302nm and 366nm is absorbed by the bound dye itself.  In both cases, 
the energy is re-emitted at 590nm in the red-orange region of the visible spectrum. 
Because the fluorescent yield of ethidium bromide-sequence-DNA complexes is 20-
30 fold greater than that of unbound dye, bands containing as little as 10ng of DNA 
can be  detected  in  the  presence  of  free  ethidium bromide  (0.5  μg/ml)  in  the  gel. 
Ethidium bromide can be used to detect both single and double stranded nucleic acids. 
However, the affinity of the dye for single stranded nucleic acid is relatively low and 
the fluorescent yield is comparatively poor.   In fact, most fluorescence associated 
with staining single stranded DNA or RNA is attributable to binding of the dye to 
short intrastand duplexes in the molecules.
Ethidium bromide is prepared as a stock solution of 10mg/ml in water, which 
is stored at room temperature in dark bottles or bottles wrapped in aluminum foil. 
The dye  is  usually incorporated into agarose gels and electrophoresis  buffers at  a 
concentration of 0.5  μg/ml. Although the electrophoretic mobility of linear double-
stranded DNA is reduced by 15% in the presence of the dye, the ability to examine 
the agarose gels directly under UV illumination during or at the end of the run is a 
great advantage.  However, sharper DNA bands are obtained when electrophoresis is 
carried  out  in  the  absence  of  ethidium bromide.   During  restriction  digestion  the 
agarose  gel  should  be  run  in  the  absence  of  ethidium bromide  and  stained  after 
electrophoresis  is  complete.   Staining  is  accomplished  by  immersing  the  gel  in 
electrophoresis  buffer  or  water  containing  ethidium bromide for  30-45 minutes  at 
room temperature.   Destaining is not usually required. However, detection of very 
small amounts (<10ng) of DNA is made easier if the background fluorescence caused 
by unbound ethidium bromide is reduced by soaking the stained gel in water or 1mm 
MgSO4 for 20 minutes at room temperature.
(v) The applied voltage:
At low voltages, the rate of migration of linear DNA fragments is proportional 
to the voltage applied.  However, as the strength of the electric field is raised, the 
mobility  of  high-molecular  weight  fragments  increases  differentially.   Thus,  the 
effective range of separation in agarose gels decreases as the voltage is increased.  To 
obtain maximum resolution of DNA fragments >2kb in size, agarose gels should be 
run at no more than 5-8V/cm.
(vi) The type of agarose:
The  two  major  classes  of  agarose  are  standard  agaroses  and  low-melting 
temperature  agaroses.   A  third  and  growing  class  consists  of  intermediate 
melting/gelling temperature agaroses, exhibiting properties of each of the two major 
classes. 
(vii) The electrophoresis buffer:     
The electrophoretic mobility of DNA is affected by the composition and ionic 
strength of the electrophoresis buffer.  In the absence of ions electrical conductivity is 
minimal and DNA migrates slowly, if at all, In buffer of high ionic strength electrical 
conductance  is  very  efficient  and significant  amounts  of  heat  are  generated,  even 
when moderate voltages are applied.  In the worst case, the DNA denature.
1.5.2 TYPES OF ELECTROPHORESIS BUFFER:
Several different buffers are available for electrophoresis  of native,  double-
stranded DNA.  These contain Tris-acetate and EDTA (pH 8.0; TAE) (also called TE 
buffer), Tris borate (TBE) or Tris-phosphate (TPE) at a concentration of 50mM (pH 
7.5-7.8).  Electrophoresis buffers are usually made up as concentrated solutions and 
stored at room temperature. All these buffers work well, and the choice among them 
is largely a matter of personal preference.  TAE has the lowest buffering capacity of 
the three and will become exhausted if electrophoresis is carried out for prolonged 
periods of time.  
When  this  happens,  the  anodic  portion  of  the  gel  becomes  acidic  and 
bromophenol blue migrating through the gel toward the anode changes in color from 
bluish-purple to yellow.  This change begins at pH 4.6 and is complete at pH 3.0. 
Exhaustion  of  TAE can be  avoided by periodic  replacement  of  the  buffer  during 
electrophoresis  or by recirculation of the buffer between the two reservoirs.  Both 
TBE and TPE are slightly more  expensive than  TAE, but  they have  significantly 
higher  buffering  capacity.   Double  stranded  linear  DNA  fragments  migrate 
approximately  10% faster  through  TAE than  through  TBE  or  TPE  the  resolving 
power of TAE is slightly better than TBE or TPE for high molecular weight DNAs 
and worse for low-molecular weight  DNAs.  This difference probably explains the 
observation that electrophoresis in TAE yields better resolution of DNA fragments in 
highly complex mixtures such as mammalian DNA.  
Gel loading buffers are mixed with the samples before loading into the slots of 
the gel.  These buffers serve three purposes They increase the density of the sample, 
ensuring  that  the  DNA sinks  evenly  into  the  well;  they add color  to  the  sample, 
thereby simplifying the loading process and they contain dyes that in an electric field, 
move toward the anode at  predictable  rates,   Bromophenol  blue migrates  through 
agarose gels approximately 2.2 fold faster than xylene cyanol FF, independent of the 
agarose concentration.  Bromophenol blue migrates through agarose gels run in 0.5x 
TBE at approximately the same rate as linear double stranded DNA 300bp in length, 
whereas xylene cyanol FF migrates at approximately the same rate as linear double-
stranded DNA 4 kb in length.  These relationships are not significantly affected by the 
concentration of agarose in the gel over the range of 0.5-1.4%. 
Agarose gels are cast by melting the agarose in the presence of the desired 
buffer  until  a  clear,  transparent  solution  is  achieve.   The  melted  solution  is  then 
poured into a mold and allowed to harden.  Upon hardening, the agarose forms a 
matrix, the density of which is determined by the concentration of the agarose4.
Agarose concentration in gel (%w/v) Range of separation of  linear DNA 
(kb)
0.3 5-60
0.6 1-20
0.7 0.8-10
0.9 0.5-7
1.2 0.4-6
1.5 0.2-3
2.0 0.1-2
Table 3: Range of separation in Gels containing Different amounts of standard 
agarose.
The DNA fragments  that  results  from restriction  enzyme cutting are easily 
separated and displayed by electrophoresis through agarose gels. 
1.6. POLYMERASE CHAIN REACTION
PCR  is  an  invitro  method  for  the  enzymatic  synthesis  of  specific  DNA 
sequences using two oligonucleotides primers that hybridize to opposite strands and 
flank the region of interest in the target DNA.  A repetitive series of cycles involving 
template denaturation, primer annealing and the extension of the annealed primers by 
DNA  polymerase  results  in  the  exponential  accumulation  of  a  specific  fragment 
whose termini are defined by the 5’ends of the primers.  Because the primer extension 
products synthesized in one cycle can serve as a template in the next, the number of 
target DNA copies approximately doubles at every cycle.  Thus 20 cycles of PCR 
yields about a million fold (220) amplification. PCR was invented by Karry Mullis was 
originally  applied  in  Human Genetics  department  at  Cetus to  the amplification  of 
human β-globin DNA and to the prenatal diagnosis of sickle-cell anaemia. PCR was 
first proposed in early 1970’s by H. Ghobind Khorana and put in practice by Kary 
Mullis and co-workers at Cetus4.
An important  property of  PCR particularly in  diagnostic  application  is  the 
capacity to amplify a target sequence from crude DNA preparations as well as from 
degraded DNA templates.
1.6.1 ESSENTIAL COMPONENTS OF PCR:
 A thermostable DNA polymerase to catalyze template dependent synthesis 
of DNA.  Taq Polymerase (0.5-2.5U).
 A  pair  of  synthetic  oligonucleotide  to  prime  DNA  synthesis.  Primers 
should be selected with a random base distribution, and with a GC content 
similar  to  that  of  fragment  being  amplified.   Primers  with  stretches  of 
polypurines polypyrimidines or other unusual sequence should be avoided. 
In  particularly  avoiding  primers  with  3’end  overlaps  will  reduce  the 
incidence  of  primer  dimer.   Concentration  0.05-0.5μM  of primer  is 
acceptable.   Primer  dimer  is  an  amplification  artificant  observed  when 
many cycles of amplification are performed on a sample containing very 
few initial  copies  of template.   It  is  a double stranded fragment  whose 
length is very close to the sum of two primers and appears to occur when 
one  primer  is  extended  by  the  polymerase  over  the  primer.  High 
concentration of primers favour mispriming which may lead to nonspecific 
amplification
 dNTPs 200-250 μM of each dNTP are recommended for Taq polymerase 
in reactions containing 1.5mM MgCl2.
 Buffer  to  maintain  pH  :  Tris-Cl  (pH  8.3-8.8).  Monovalent  cations: 
Standard PCR buffer contains 50 mM KCl and works well or amplification 
of segments of DNA >500 bp in length. 1.5  mM MgCl2  is optimal (200 
μM each dNTP).  Generally excess Mg2+  may results in the accumulation 
of non-specific amplification products and insufficient Mg2+  will  reduce 
the yield.
 Template DNA: In case of mammalian gDNA up to 1.0 μg of DNA is 
utilized/reaction an amount that contains approximately 3x 105copies of a 
single copy autosomal gene.
 Thermostable  DNA  polymerases:  This  is  isolated  from two  classes  of 
organisms  the  thermophilic  and  hyperthermophilic  eubacteria 
Archaebacteria.  Sometimes cocktails are preferred.
PCR  in  short  is  denaturation  of  the  template  by  heat,  annealing  of  the 
oligonucleotide primers to the single stranded target sequence and extension of the 
annealed primers by a thermostable DNA polymerase56. Process usually involves the 
following:
1.6.2 Denaturation:
dsDNA template denature at  a temperature i.e.,  determined in part by their 
G+C content.  The higher the proportion of G+C, the higher the temperature required 
to separate the strands of template DNA.  The longer DNA molecules the longer time 
required to separate. If temperature is short or time is short, only AT rich regions of 
the template DNA will be denature.  When the temperature is reduced later in the 
PCR cycle the template  DNA will  reanneal  into a fully native condition.   This is 
carried out at 94-95 0C which is the highest temperature the enzyme can endure for 30 
or more cycles.  Higher temperature may be required to denature template that are 
rich in G+C content.  DNA polymerases isolated from Archae are more heat tolerant 
than Taq.
1.6.3 Annealing:
If  Annealing  temperature  is  too  high  the  oligonucleotide  primers  anneal 
poorly, yield is also low.  If temperature is low nonspecific annealing of primers may 
occur, resulting in unwanted amplification.
1.6.4 Extension of oligonucleotide primers: 
72-78 0C is the optimum temperature for extension.  The polymerization rate 
of Taq polymerase in approximately 2000 nucleotides/min and carried for 1 min for 
every 1000 bp of product.   Result  of PCR is not altered by using 3 times longer 
extension time.   
Standard reaction
The standard PCR is typically done in a 50 or 100 μl volume an in addition to 
the sample DNA contains 50 mM KCl, 10 mM Tris HCl (pH 8.4), 1.5 mM MgCl2, 100 
μg/ml gelatin, 0.25 μM of each primer, 200 μM of each deoxynucleotide triphosphate 
(dATP, dCTP, dGTP, dTTP) and 2.5 U of Taq polymerase.
1.6.5 RAPD-PCR46
RAPD stands for random amplification of polymorphic DNA. It is a type of 
PCR reaction, but the segments of DNA that are amplified are random.  No knowledge 
of  the  DNA sequence  for  the  targeted  gene  is  required,  as  the  primers  will  bind 
somewhere in the sequence, but it is not certain where exactly it binds. This makes the 
method popular for comparing the DNA of biological systems that have not had the 
attention of the scientific community,  or in a system in which relatively few DNA 
sequences are compared (it is not suitable for forming a DNA databank). Due to the 
fact that it relies on a large, intact DNA template sequence, it has some limitations in 
the use of degraded DNA samples. Its resolving power is much lower than targeted, 
species specific DNA comparison methods, such as short tandem repeats. In recent 
years, RAPD is used to characterize, and trace, the phylogeny of diverse plant and 
animal species.
1.7. POLYMORPHISMS
         Variation whatever may be its cause and however it may be limited, is the 
essential phenomenon of evolution.  The  readiest way, then of solving the problem of 
evolution  is  to  study the  facts  of  variation.---William Bateson (1894).   The  term 
polymorphism  has  been  defined  as  a  ‘Mendelian  trait’  that  that  exists  in  the 
population in at atleast 2 phenotypes, neither of which occurs at a frequency of less 
than 1%.  Some DNA polymorphisms are neutral single base pair changes detected by 
virtue of the consequent introduction or removal of a  restriction enzyme recognition.
These are variations in DNA sequence between individuals.  There are about 
60,000 polymorphisms in human genome27.   RFLPs are not  rare  being distributed 
throughout  the  genome  at  a  frequency  of  between  1/200  and  1/1000  bp.   Not 
unexpectedly,  the  vast  majority  of  polymorphisms  occurs  in  introns  or  intergenic 
regions rather than within coding sequences and may thus be expected to be neutral 
with respect to fitness.  Those polymorphisms that occur either in coding regions or in 
the promoter region may however affect whether the structure or function of the gene 
product or the expression of the genes and may have the potential to be of phenotypic 
or  even  pathological  significance.   Restriction  enzymes  are  named  based  on  the 
bacteria in which they are isolated in the following manner:
E                                   Escherichia (genus)
Co                                 coli             (species)
R                                    RY13           (strain)
I                                     First identified  Order ID’d in bacterium
Enzyme Source
Recognition 
sequence
Cut Average 
Fragment 
Size
(Kb)
Estimated 
number of 
sites
EcoR I Escherichia coli
5’ GAATTC
3’ CTTAAG
5’---G     AATTC---3’
3’---CTTAA     G---5’
5 6x105
BamHI
Bacillus  
amyloliquefaciens
5’ CCWGG
3’ GGWCC
5’---G      GATCC---3
3’---CCTAG      G---5’
5 7.5x105
HindIII
Haemophilus  
influenza
5’ GGATCC
3’ CCTAGG
5’---A      AGCTT---3’
3’---TTCGA      A---5’
4 6x105
Table 4:  Restriction enzymes and their property 
1.7.1 RFLPS:
In practice the DNA of many individuals of one lineage is first cleaved with a 
restriction enzyme which exhibits a probe.  At present approximately 200 different 
RFLP probes for a total of 10 restriction enzymes have already been identified and 
employed for mapping purpose. Occasionally RFLPs may also be caused by more 
complex phenomena such as deletions or insertions.  DNA polymorphisms offer a 
number of advantages for mapping genomes firstly number of DNA markers already 
exceeds  that  of  suitable  protein  markers,  secondly  a  DNA  sequences  does  not 
necessarily  have  to  express  a  protein  in  order  to  be  identified  by  polymorphism 
cleavage  sites.   DNA polymorphisms  can  of  course occur  in  any DNA sequence 
particularly in introns. 
RFLPs are especially useful for identifying genetic defects in humans and can 
be exploited for diagnostic purposes as long as the DNA alternations involved do not 
occur several times, and are associated with single genes.  Most of the RFLPs known 
today appear to have occurred randomly and bear no relation to neighboring gene.
RFLPs were first used for characterizing mutant viruses.  In humans, RFLPs 
were  first  identified  in  the  vicinity  of  the  globin  gene  and  have  been  used  for 
diagnosing sickle cell anaemia.  It can be also used for mapping genes and hence for 
characterizing genetic defects even if the gene in question is completely unknown28.
1.7.2 Mutation specific RFLPs29:
In some single gene disorder the mutation responsible eliminates a restriction 
enzyme recognition site.  This direct approach has been used in sickle-cell disease 
using the Restriction enzyme Mst II.
Variation  in  the  nucleotide  sequence  of  the  human  genome  is  common, 
occurring approximately once every 200 bp.  These single base pair differences in 
DNA nucleotide sequences are inherited in a Mendelian codominant manner and have 
no  phenotypic  effects  as  they usually  occur  in  intergenic  non-coding DNA.  If  a 
difference in DNA sequence occurs within the nucleotide recognition sequence of a 
restriction  enzyme  the  DNA fragments  produced  by that  RE will  be  of  different 
lengths in different people.  This can be recognized by the altered mobility of the 
restriction fragments on gel electrophoresis.
1.7.3 Restriction enzyme digestion:
       Restriction digestion is the process of cutting DNA molecules into smaller pieces 
with  special  enzymes  called  Restriction  endonucleases  or  Restriction  enzymes. 
Restriction enzymes are bacterial enzymes which cut (hydrolyse) DNA into defined 
and  reproducible  fragments.   In  bacteria,  they  form  part  of  the  Restriction 
modification defense mechanism against foreign DNA.  They are basic tool for gene 
cloning.   These  special  enzymes  recognize  specific  sequences  called  palindromic 
sequence in the DNA molecule and cleave symmetrically in both strands.  Restriction 
digestion begins by mixing the DNA and the Restriction enzyme.  The actual reaction 
conditions vary from one enzyme to the next and include temperature, NaCl and/or 
MgCl2, concentration, pH.  All of these variables except temperature are optimized by 
mixing the enzyme and DNA with a buffer specific for the enzyme of choice.  Once 
the ingredients are mixed in the reaction tube, the tube is incubated at the reaction 
optimal temperature for 1 hour or longer.  Then finally when the digest has run for the 
appropriate amount of time, the reaction tube is put back on ice to prevent nonspecific 
degradation of DNA.  The principle behind the technology rests on the possibility of 
comparing band profiles generated after Restriction digestion in  DNA molecules of 
different  individuals.   Diverse  mutations  that  might  have  occurred  affect  DNA 
molecules  in  different  ways  producing  fragments  of  variable  lengths.   These 
differences in fragment lengths can be seen after gel electrophoresis30. 
2. REVIEW OF LITERATURE
 Ingrid  Meulenbelt  et  al.,36 (1995),  adopted  non-invasive  DNA sampling  and 
isolation method involving oral samples  taken with cotton swabs.  Out of 262 
DNA samples isolated using mouth swabs, 257 were successfully used in PCR 
reactions  of  20  different  human  loci.  They also  found that  phenol/chloroform 
extractions used to isolate uncontaminated genomic DNA without yeast spores or 
bacteria could be used for DNA analysis other than PCR. They have used this 
method  for  genetic  linkage  study,  various  genetic  population  studies,  and  in 
zygosity determination of twin  pairs.
 Amy H. Walker et al,37 (1999), processed 995 buccal swabs for use in PCR based 
genotype assays.  They processed biosamples for as long as 3 years and found no 
appreciable decrease in the rate of PCR success.  They concluded that adequate 
DNA  for  PCR-based  applications  could  be  obtained  from  buccal  swabs,  but 
sampling or processing considerations might be important in obtaining optimal 
results.
 Lea C.  Harty  et  al., 18 (2000),  devised  a  simple,  non invasive,  cost  efficient 
technique     for collecting buccal cell DNA for molecular epidemiology studies. 
Subjects brushed their  oral  mucosa  and expectorated  the fluid in  their  mouths 
which  was  applied  to  Guthrie  cards  pretreated  to  retard  bacterial  growth  and 
inhibit    nuclease   activity.  The cards were well suited for transport and storage 
because they dry quickly, need no processing and were compact and lightweight. 
They concluded that treated cards were an alternative to brushes/swabs and mouth 
rinses for collection of buccal cell  DNA and offer some advantages over other 
methods.
 Lea C. Harty  et al.,17 (2000),  found that self collection of oral epithelial cells 
under the direction of a trained interviewer yielded similar quantities of DNA as 
clinic based collection by a medical technician and larger quantities of DNA were 
obtained from men than from women.   Men may have larger  buccal  mucosal 
surface  areas  or  may  brush  harder,  thereby  loosening  more  cells.   Thus,  self 
collection of DNA by using oral rinses could be a suitable method for obtaining 
high quality samples and achieving high participation rates.
 Loie Le Marchand  et al.,38 (2001),  assessed the feasibility of obtaining buccal 
cell DNA by mail from participants in a large community based cohort study I in 
Hawaii.   They found that the mean DNA yield was lower in females (41.7µg) 
than in  males (53.4 µg) and in Japanese (37.8 µg) as compared with Hawaiians 
(51.9 µg) and Caucasians (54.8 µg).  All samples were successfully genotyped or 
polymorphisms in the CYP1A1, CYP2E1, GSTM1, GSTT1 and NQO1 genes by 
PCR-RFLP.   From  these  data  they  concluded  that  in  situations  where  blood 
samples  cannot  be obtained,  mail  collection  of  mouthwash samples  should  be 
considered because it  yielded substantial  amounts  of high quality   gDNA for 
large number of study subjects.
 Heather Spencer Feigelson et al.,29 (2001), used a mouthwash protocol to collect 
six daily buccal cell samples from 35 healthy volunteers.  They determined total 
DNA, human specific(hDNA), degradation  of  DNA, and ability  to  amplify by 
PCR.   However  tooth  brushing  1  hour  before  sample  collection  reduced  the 
amount of hDNA by nearly 40%.  Their results suggests that buccal cells should 
be collected before brushing teeth and processed within 5 days of collection to 
maximize hDNA yield.
  Schichun Zheng et al.,40 (2001), collected buccal samples from  children ranging 
in age   from 4 months to 15 years.   They evaluated a technique that involves 
Whole  Genome  Amplification  using  the  improved  primer  extension 
preamplification method.   They reported that the standard buccal protocol failed 
to yield successful PCR reactions in 30-51% of specimens whereas WGA buccal 
protocol however produced   genotyping results fully concordant with the referent 
blood or bone marrow DNA results   for all   fine loci,  and is very useful for 
improving the efficiency and validity of PCR    based   genotyping in pediatric 
populations.
 Ellen M. Heath  et al.,19 (2001), developed a noninvasive sampling method for 
collecting cells for routine DNA testing in a clinical laboratory setting. Of the five 
mouthwashes  tested,  Scope  brand  mouthwash  received  the  highest  overall 
ranking. They found in  a 4 week, room temperature stability study, the DNA in 
mouthwash samples was stable for at least  2 weeks, yields ranged from around 
12-60 µg/ donor,  and the DNA   was  of  high  quality  and the yield was suitable 
for  use  in  downstream  analytical  application  such  as  Southern  blotting, 
amplification analysis, sequencing and archiving.
 Montserrat Garcia-Closas et al.,11 (2001),  conducted a two phase study and  in 
phase I they compared cytobrush and mouthwash samples collected by mail  in 
two different epidemiological studies (a) cytobrush samples (n=120) from a US 
case  control  study  of  breast  cancer  (b)  Mouthwash  samples  (n=40)  from 
prospective cohort of male US farmers. Findings from phase I were confirmed in 
phase Ii  where  they randomized  cytobrush  (n=28) and (n=25) samples  among 
participants  in  the  breast  cancer  study and compared both collection  methods. 
The median human DNA yield determined by hybridization with a DNA probe 
from Phenol chloroform extracts was 1 and 1.6 μ/2 brushes for phase 1and 2, and 
27.5 and 16,6 µg per mouthwash samples for phase 1 and 2 respectively.  Most 
(94-100%) mouthwash extracts contained high molecular weight DNA(>23kb) in 
contrast to 55-61% of brush extracts.  They concluded that a single mouthwash 
sample provided substantially higher molecular weight DNA than two cytobrush 
sample.
 Stephanie J. London  et al.,41 (2001)   collected large quantities  of buccal cell 
DNA in school children.  They brushed each buccal surface with a soft toothbrush 
and  then  rinsed  with  10ml  of  water.   They  preferred  the  toothbrush  method 
because of the higher total  DNA yields and greater success in generating PCR 
products.  Out of 1563, samples they obtained results for SNP in the interleukin-
13  gene(at  2044)  by  RFLP-PCR  on  98.8%  and  in  the  promoter  at  the 
myeloperoxidase gene (at 463) by real time PCR on 99.7%.
 Karen  Steinberg  et  al.,7 (2002),   have  reviewed  current  practices  for  DNA 
Banking in Epidemiology studies and  focused on 4 types of specimens namely 
whole blood preserved as dried blood spots, whole blood from which gDNA is 
isolated, immortalized lymphocytes from whole blood or separated lymphocytes 
prepared  immediately  or  subsequent  to  cryopreservation  and  buccal  epithelial 
cells.  They concluded that gDNA from whole blood was the safest assurance for 
most  current  and  future  molecular  applications.  Buccal  cells  were  considered 
when noninvasive self-administered or mailed collection protocols were required.
 Satia-Abouta  et al.,25 (2002),  compared the DNA yield, quality and associated 
costs  of  buccal  cell  DNA  collected  using  cytobrushes  and  swish  in  self-
adminstered procedures.  They found a non-statistically significant higher yield 
from  mouthwash  compared  with  cytobrush  collections  (15.8  µg  vs.  12.0  µg 
respectively).   They concluded that  collection  of DNA with cytobrushes  using 
simple instructions was cost effective in large scale studies and yielded sufficient 
quantity and quality of DNA for genotyping.
 Tara Engeman Andrisin et al.,42 (2002), determined long term stability, quantity 
and quality of genomic DNA samples collected in buccal cells by the mouthwash 
method, for use in pharmacogenetic studies.  They concluded that genomic DNA 
in mouthwash was stable  for prolonged periods at  room temperature,  and was 
sufficient for pharmocogenetic studies.
 Philip E. Castle  et al.,43 (2003),   collected buccal cells from 29 participants, by 
use  of  mouthwash  rinses  and  were  split  into  equal  aliquots,  with  one  aliquot 
irradiated by electron beam irradiation equivalent to the sterilizing dosage of U.S. 
Postal services and the other left untreated.  They checked that irradiated aliquots 
had  lower  median  DNA  yields  (3.7µg/aliquots)  than  untreated  aliquots  (7.6 
µg/aliquots) and were more likely to have smaller maximum DNA fragment size 
on the basis of genomic integrity gels, than untreated aliquots.  They concluded 
that E-beam irradiation reduced the yield and quality of buccal cell specimens and 
although irradiated buccal cell specimens may retain sufficient DNA integrity for 
some amplified  analyses  of  many common genomic  targets,  assays  that  target 
longer DNA fragments (>989 bp) or require whole genome amplification may be 
compromised. 
 T.  Neuhas  et  al.,20 (2004),  used  Light  Cycler  technology in  analysis  of  non-
invasively  derived  DNA.   DNA extracted  from blood,  mouthwash and buccal 
cytobrush  samples  from  100  volunteers  were  analyzed  for  the  genotypes  of 
cytochrome  P450,  CYP1B1,  glutathione-S-transferases  GSTT1,  GSTM1  and 
GSTP1.   The  median  amounts  of  DNA isolated  from blood,  mouthwash  and 
buccal cytobrush samples were 95,11 and 8µg respectively.
 Audrey F Saftlas  et  al.,26 (2004), tested  two cytobrush  collection  methods  to 
optimize  total  DNA  yield  and  purity  for  HLA  (Human  Leukocyte  Antigen) 
genotyping  in  mothers  and infants.  One was  brushing the  left  and right  inner 
cheeks and the second was brushing the upper and lower gutters.  Mother gutter 
samples yielded higher amounts of DNA than cheek samples.  While DNA yield 
from  cheek  and  gutter  collections  from  infants  were  equivalent.   They  also 
concluded that cytobrushes stored in paper envelopes yielded significantly more 
and higher purity DNA than brushes in plastic bags or tubes.
 Clarie Mulot  et al.,44 (2004),  compared the gDNA obtained from buccal cells 
through mouthwash, cytobrush and treated cards. They analyzed the amount and 
quality  of DNA and the influence of a lag time at room temperature to simulate 
delays of sample mailing.  They found that mouthwash was more expensive, than 
cytobrush.   The cytobrush  method  appeared  to  be more  appropriate  for  them. 
They also  demonstrated  that  cytobrushes  could  be  used  for  studies  with  very 
young subjects, on a large scale.
 Dominique Quinque  et al.,8  (2006), developed a simple noninvasive procedure 
for saliva sample collection, DNA collection and DNA extraction.  The average 
amount of human DNA was about 11.4 μg/ml of saliva which was more than the 
DNA  obtained  from  other  noninvasive  samples  such  as  cheek  swabs.   They 
determined  the  amount  of  human  specific  genomic  DNA  by  TaqMan  assays 
which varied from 5.7 to 100% of the total DNA, suggesting nonhuman DNA was 
present in the extracts.  
 Priya  Koppikar  et  al.,16 (2006),  evaluated  that  good  quality  high  molecular 
weight genomic DNA can be obtained from exfoliated cells in the early morning 
mouthwash  samples,  and  that  the  DNA yield  from similar  samples  decreases 
during  the  day,  with  very  low yields  obtained  in  the  late  evening.  They  also 
determined that DNA so obtained was successfully amplified by PCR, and can be 
used for further studies like RFLP.
3. AIM AND OBJECTIVE
Interest  in genome-wide association studies to identify susceptibility alleles 
for  cancer  is  growing,  and several  are  currently planned or under  way.  A critical 
requirement  for  such large  scale  studies  is  the  amount  of  DNA available  from a 
sample.  Traditionally whole blood is the tissue of choice, as the yield of DNA is quite 
high  (typically  10-15  μg/ml).   However  obtaining  a  blood  sample  is  an  invasive 
procedure that requires training in phlebotomy, and moreover blood samples require 
refrigerated storage and must be processed within a week or so of collection together 
they may cause potential hazard to the handlers.
The present study was aimed at investigating the suitability of analyzing the 
genotype  by  using  genomic  DNA  collected  non-invasively  by  mouthwash  in 
association with the RAPD-PCR approach and by studying genetic polymorphisms by 
RFLP. In the light of the fact that over 90% cancers involve epithelial cells and that 
DNA  damage  is  considered  a  crucial  mechanism  in  cancer  development,  the 
evaluation  of  DNA  damage  in  buccal  epithelial  cells  may  thus  provide  a  good 
biomarker of early damage in target tissues.21
Working with human genome, Botstein  proposed the use of DNA fragments 
as genetic markers for monitoring segregation. The first molecular markers to be used 
were  fragments  produced  by  digestion  of  DNA  with  restriction  enzymes.   The 
variation  in  fragment  size  obtained  from  different  individuals  after  the  digestion 
created the class of markers called restriction fragment length polymorphism (RFLP). 
If we compare the restriction map of DNA from patients suffering from a disease with 
the DNA of a normal people, we may find that a particular restriction site is present or 
absent from the patients.                                                
Molecular markers are DNA fragments that can be used as a fingerprint in the 
identification  or  characterization  of  individuals.  These  markers  have  become  an 
increasingly helpful tool in genetic research and applications to biotechnology. The 
basic premise behind molecular markers is that there is natural genetic variation in 
individuals, and many genetic sequences are polymorphic, meaning they differ among 
individuals.  The objective of this work is to find out the variation i.e., polymorphism 
which would be helpful in diagnosing genetic defects.  Molecular markers seek to 
exploit this variation to identify individuals, traits, or genes on the basis of genetic 
differences.
The  RFLP  performed  was  to  find  variation  between  individuals  namely 
healthy,  tobacco  users  and  cancer  patients  by  exposing  their  DNA  to  
Restriction enzymes and running an aliquot of the resulted DNA on 1% Agarose.  The 
DNA will  be  separated  according  to  their  molecular  weight  and  bands  generated 
would  be  useful  in  tracing  out  the  difference.   This  property  can  be  used  for 
diagnosing genetic defects. 
4. PLAN OF WORK
A. Selection of volunteers and collection of mouthwash samples.
Volunteers  mainly  chosen  were  healthy  persons,  tobacco  chewers,  cancer 
patients  preferably  with  oral  cancer.  The  mouthwash  chosen  were  4%  sucrose 
solution, 0.9% saline and 2 branded mouthwashes.
B. Isolation of genomic DNA from mouthwash samples using, 
i) simple protocol including NaCl, EDTA, NaOH, & Tris Hcl.
ii) a lengthy  protocol using phenol chloroform extraction.
C. Agarose gel electrophoresis
1% agarose gel was used to find out the purity and yield of DNA present in the 
samples.
D. Quantification of DNA by using UV spectrophotometer.
The DNA sample was diluted in the ratio of 1: 100 with sterile water or TE 
buffer. The absorbance was measured at 260nm and calculated accordingly.
E. (RAPD) Polymerase chain reaction (PCR).
DNA  samples  were  amplified  using  unknown  sequence  and  known  IFN 
primer to check the source and integrity of DNA obtained..
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F. Restriction Fragment Length Polymorphism (RFLP).
DNA samples were digested using two restriction endonucleases  to find out 
the polymorphism undergone. 
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5. MATERIALS AND INSTRUMENTS USED
MATERIALS USED
S.No Chemical Name Company
1 Sodium Chloride LOBA CHEMI MUMBAI
2 EDTA s d-fiNE CHEMICALs MUMBAI
3 Sodium Hydroxide s d-fiNE CHEMICALS MUMBAI
4 Tris HCl HI-MEDIA MUMBAI
5 Sodium Dodecyl Sulphate s d-fiNE CHEMICALS MUMBAI
6 Proteinase K GENIE
7 Phenol s d-fiNE CHEMICALS MUMBAI
8 Chloroform s d-fiNE CHEMICALS MUMBAI
9 Sodium acetate NICE
10 Ethanol Sakthi sugars ltd, Appakoodal
11 Agarose HI-MEDIA MUMBAI
12 Ethidium Bromide HI-MEDIA MUMBAI
13 Bromophenol blue HI-MEDIA MUMBAI
14 Sucrose LOBA CHEMI MUMBAI
15 Boric acid INDIAN  PHARMACEUTICALS 
CHENNAI
16 Eco RI MEDOX CHENNAI
17 Bam HI MEDOX CHENNAI
18 Hind III MEDOX CHENNAI
19 PCR KIT GENEI BANGALORE
20 Primer GENEI BANGALORE
21 Tris base HI-MEDIA
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INSTRUMENTS USED
S.No Instrument name Company
1 Autoclave NEW LAB EQUIPMENT
2 Cooling Centrifuge REMI MOTOR LTD
3 Digital Balance SHIMADZU
4 Deep Freezer BLUE STAR
6 Digital pH Meter ELICO
7 Double  beam  UV-Visible 
Spectrophotometer
ELICO
8 Electronic Digital Water bath GENUINE
9 Hot Air Oven GENUINE
10 Laminar Air Flow GENUINE
11 Refrigerator Godrej
12 Agarose gel apparatus GENUINE
13 PCR EPPENDORF  THERMAL 
CYCLER
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6. METHODOLOGY
6.1 Selection of participants and collection of mouthwash samples:
For this randomized crossover study, 29 participants from in and around Erode 
district  were  selected.  14 Women (Mean Age 52),  15 Men (Mean Age 49)  were 
approached for mouthwash samples.  25 compiled the study. 4 participants ignored 
the study and did not provide sample.
Volunteers were classified into three categories namely
i) Normal or healthy patients who did not have any smoking or tobacco chewing 
habits and led a good healthy life. In this category 4 (2 men and 2 women) 
samples were collected.
ii) Tobacco chewers are those who were exposed to smoke or tobacco in any 
form  and  were  chewing  tobacco  for  more  than  10  years  with  or  without 
smoking or alcohol.  In this category 16 samples were collected (11 men and 5 
women).
iii)     Cancer patients are those who have been diagnosed with tumours. Oral cancer  
patients  are  almost  preferred  but  due  to  limited  numbers  other  cancer  like 
stomach  and  rectal  cancer  patients  were  selected  around  Erode  and  were 
undergoing chemotherapy and radiation treatment as inpatients in hospital. 5 
participants (4 women and 1 man) were approached for their samples. 
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Procedure for sample collection:
 A day before in evening volunteers was approached with a sterile leak tight 
cup with lid  as  a  collection  vessel  containing  the  solution to  be swished 
inside their mouth.  The solutions used were 4% sucrose, 0.9% saline, and 
two commercial brands Rexidine and Listerine.
 A consent  form containing  information  to  be  filled  regarding  their  Age, 
Gender,  Tobacco  chewing  habits  and  other  particulars.  To  protect  the 
confidentiality  of  these  genetic  tests  multiple  safeguards  were  taken. 
Collection containers were identified by numbers not by names.  Names of 
the participants will not be used in any of the reports.  The study results are 
reported in statistical summary only12.
 They were asked to swish 15 ml of the mouthwash solution vigorously for 60 
seconds the next  day morning before brushing their  teeth16.  The solution 
should  be  moved  from  cheek  to  cheek  without  gargling  as  gargling 
introduces phlegm from throat which is not conducive to resuspension or 
automated  tipmixing31.   When  spitting  it  was  ensured  that  the  entire 
mouthwash sample was collected into the sterile container to maximize the 
yield.   More cells  meant  more DNA. The entire  process required only 5 
minutes.   Note  :  No  food  or  drink  should  be  consumed  before  sample 
collection.
 The samples  were  collected  in  the  next  morning  and brought  to  lab  and 
processed for isolation of DNA.
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6.2.   ISOLATION OF DNA:
After bringing the mouthwash sample to the lab it was processed according to 
two protocols to find out which protocol yielded more and pure amount of DNA.
Protocol I [M.J., Mac Pherson]32.
a) The buccal epithelial cells were collected by directly centrifuging at 10,000 
rpm for 10 min at room temperature and the supernatant was discarded.
b) The pellet obtained was resuspended in 500 μl of 10 mM NaCl and 10 mM of 
EDTA (pH 7.5) and transferred to a screw-capped microcentrifuge.
c) This solution was centrifuged for 15 sec and the supernatant was discarded.
d) The cell pellet was again resuspended in 500 μl of 50 mM NaOH by vortexing 
for 10 sec.
e) The sample was incubated at 100 °C for 5min.
f) The sample was neutralized with 100 μl of 1 M Tris-HCl and vortexed for 5 
seconds.
g) Again  the  samples  were  centrifuged  for  15  sec  to  remove  cell  debris  and 
supernatant was retained which contained the buccal cell DNA.
h) 5 μl of DNA prepared in this way was sufficient for a single PCR reaction.
Protocol II [Walsh, D.J., et al33. and Lum A., Le Marchand34].
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a) Mouthwash sample were placed in 50 ml conical tube and centrifuged at 2700 
rpm for 15 min.  The supernatant was dumped and the pellet were resuspended 
in  25ml  of  T10E10  to  remove  residual  mouthwash  from the  sample.  The 
samples were centrifuged at  2700 rpm for 15 min and the supernatant  was 
dumped.
                         Composition of T10E10
1M Tris/HCl (pH 8.0) =10ml
0.5M EDTA (pH 8.0) = 20ml
Total volume = 1000ml
b). The pellets obtained were   resusupended in 700 μl of lysis buffer.
                        Composition of Lysis buffer
10mM TrisHCl   (pH 8.0) = 0.1576g/100ml
10mM EDTA  (pH 8.0) = 0.3722g/100ml
0.1M NaCl = 0.5848g/100ml
2% SDS = 2g/100ml
The lysis buffer containing the pellet were transferred into a 2.0 ml microcentrifuge.
b) 35 μl 20 mg/ml Proteinase K was added to each sample and vortexed to mix. 
Then the sample was incubated at 58 °C for 2 hrs.
c) 700 μl 1:1 phenol:chloroform was added to each sample and vortexed for 10 
sec and centrifuged at 14,000 rpm for 2 min.  The supernatant was removed 
and placed in a new 2 ml microcentrifuge tube.
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d) 700  μl chloroform was added to each sample and vortexed for 10 sec and 
centrifuged  at  14,000  rpm for  2  min.   The  supernatant  was  removed  and 
placed in a new 2 ml  microfuge tube. 
e) The DNA was precipitated with 60µl of 3 M Sodium Acetate (pH 6.0). It was 
inverted to mix and 2 volumes of 100% ethanol was added inverted to mix and 
left at −20 °C for 2 hr overnight.
f) The solution was spinned at 10,000 rpm and the supernatant was discarded.
g) The pellet were washed with 500 μl 70% ethanol and spinned at 14,000 rpm 
for 2 min and the supernatant was dumped and the pellet was suspended in TE 
buffer and stored at 4 °C. 
6.3. AGAROSE GEL ELECTROPHORESIS4.
METHOD
a)  The edges of clean dry glass plate were sealed with tape to form a mold and were 
set on a horizontal section of the bench.
b)  Sufficient electrophoresis buffer was prepared to fill the tank and to cast the gel.
c)  A solution of 1% agarose in electrophoresis buffer was prepared at a concentration 
appropriate  for  separating  the  particular  size  fragments  expected  in  the  DNA 
samples. 
d)  The neck of Erlenmeyer flask was loosely plugged with Kimwipes and the slurry 
was  heated  in  a  boiling  water  bath  or  in  a  microwave  oven  until  the  agarose 
dissolves.
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e)   Insulated tongs or gloves were used to transfer the flask into a water bath at 55  °C. 
When  the  molten  gel  has  cooled,  ethidium  bromide  was  added  to  a  final 
concentration of  0.5 µg/ml and the gel solution was mixed thoroughly by gentle 
swirling. 
f)  While the agarose solution was cooling, appropriate comb was chosen for forming 
the sample slots in the gel.  The comb was positioned 0.5-1.0 mm above the plate 
so that a complete well is formed when the agarose is added to the mold. 
g)  The warm agarose solution was poured into the mold and the gel was allowed to 
set completely and a small amount of electrophoresis buffer was then poured on 
top of the gel and the comb was carefully removed.  The excess electrophoresis 
buffer was poured off and the tape was carefully removed. 
h)   The gel was mounted in the electrophoresis tank. Enough electrophoresis buffer 
was added to cover the gel to a depth of approximately 1 mm.
i) The DNA samples were mixed with 6µl of the desired 6X gel-loading buffer. The 
sample mixture  was slowly loaded into the slots  of the submerged gel using a 
disposable micropipette.   The size standards were loaded into slots on both the 
right and left sides of the gel.
j) The lid of the gel tank was closed and attached to the electrical leads so that the 
DNA will migrate toward the positive anode.  A voltage of 1-5 V/cm was applied. 
If the leads have been attached correctly, bubbles should be generated at the anode 
and cathode due to electrolysis and within a few minutes, the bromophenol blue 
should     migrate from the wells into the body of the gel4.  
50
k)  The  gel  was  run  until  the  bromophenol  blue  have  migrated  to  an  appropriate 
distance through the gel.
l) As the DNA samples or dyes have migrated a sufficient distance through the gel, 
the electric current was turned off and the leads, lids were removed from the gel 
tank  and the gel was examined under UV light4.
6.4. QUANTIFICATION OF DNA USING UV SPECTROPHOTOMETER35. 
a. DNA Measurement
1. 1:100 dilution of DNA sample was prepared with TE buffer in a  micro centrifuge 
tubes.
2. The spectrophotometer was turned on and the wavelengths were set to 260nm and 
280 nm.
3. Readings  were  taken  with  blank  having  TE  buffer  and  sample  DNA  in 
corresponding cuvette.
4. The ratio between 260 nm and 280 nm absorbance reading should be between 1.5 
and 2.0.
b. DNA quantification
The following calculation is made to quantify the DNA sample:
Absorbance 1 should contain 50µg of DNA
Therefore Absorbance at 260 nm contains ------------- [DNA] in µg/ µl  
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6.5. POLYMERASE CHAIN REACTION (RAPD-PCR)
RAPD stands for Random Amplification of Polymorphic DNA.
DNA  amplification  is  a  very  simple  method  for  in  vitro amplification  of 
specific nucleic acids using Taq DNA polymerase and minimum two oligonucleotides 
specific to the DNA to be amplified.  
Materials:
1. Taq DNA polymerase.
2. Deoxynucleotidetriphosphate mix.
3. 10X Taq polymerase buffer containining100 mM Tris HCl (pH 9.0), 
500 mM KCl, 15 mM MgCl2 and 0.1% gelatin.
4. Genomic sample DNA.
5. Primers  Forward IFN 3F: 5’ GGCACAACAGGTAGTAGGCG 3’ and 
Reverse primer, IFN 5R: 5’ GCCACAGGAGCTTCTGACAC  3’.
The reagents were added in a 500µl PCR tubes in the following order:
a) 38 µl  of sterile  MilliQ water  or  autoclaved double distilled  water  was 
added into a 0.2/0.5 ml microfuge tube.
b) 5 µl of 10X Taq polymerase assay buffer with MgCl2 was added.
c) 3 µl of 10mM dNTP mix (2.5 mM each) solution was added.
d) 1 µl of sample DNA (200 ng/ml) was added.
e) 1 µl each of forward and reverse primer (250 ng/µl) was added.
f) 1 to 2 units of Taq DNA polymerase (3 Units/µl) was also added.
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g) All these were mixed gently.
PCR program:
1) Initial denaturing at 94 °C for 9 min followed by 35 cycles of denaturing at 
94 °C for 1 min.
2) Annealing at 55 °C for 1min.
3) Extension at 72 °C for 1min.
4) Final Extension at 72 °C for 10 min. Reaction mixture without DNA served 
as negative control2.
5) The RAPD-PCR was carried in Eppendorf Thermal Cycler and the lid was 
preheated  to  102  °C  which  prevented  the  addition  of  paraffin  layer  and 
evaporation due to varying temperature.
6) After  the  reaction  was over  the  reaction  mix  was taken out  and 10µl  of 
aqueous layer was run on 1% agarose gel stained with ethidium bromide for 
1 to 2 hours at  100 volts56  and visualized under UV light for the desired 
length of DNA.
6.6. RESTRICTION FRAGMENT LENGTH POLYMORPHISM30:
Materials required:
Water bath or heating block at 37 °C or, Oven,
Micropipettes,
Agarose gel unit,
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Tubes and tips.
Reagents required:
Restriction Enzyme,
Buffer 10X,
DNA samples,
Loading dye 6X, 
0.5M EDTA, 
Sterile distilled water.
Protocol:
Buffers are usually available in the marker in a concentration 10 times that at 
which it will be used (called 10X) and the restriction enzyme which has an activity 
measured in Units where 1 unit is the amount of enzyme needed to digest 1μg of 
DNA in 1 hour. 
The following volumes of reagents were added to the reaction tube :
Reaction Mix:
Restriction enzyme 2-3 units – 0.5 μl
Enzyme buffer 10X               − 1.0 μl
DNA sample                          − 1.0 μl
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The volume was brought to 10 μl with sterile distilled water.
a)   The water and buffer  was first  put into the tube and then enzyme was added 
(Putting enzyme into the water first was avoided as it may start to break down). 
b)  The DNA sample was put in last and mixed by tapping the tube with finger.
c)  The reaction mix was quick spin to remove bubbles (as DNA will adhere to bubble 
surface and become inaccessible to enzyme).
d)  This was incubated at the recommended temperature for 1 hour.  Often 1 hour was 
sufficient for digestion but longer times are frequently used, such as overnight, to 
assure complete digestion by the enzyme.
e)   The reaction  was  stopped by adding  2.5  μl  6X loading  dye  mix,  and loaded 
directly onto agarose gel and run at 100 V for 1 to 2 hours and visualized under 
UV for DNA fragments and compared with DNA marker.
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7.   RESULTS AND DISCUSSION
7.1 Selection of participants and collection of mouthwash sample
S.No V.No. Age Gender Category Mouthwash  solution 
type
1 1 27 Female Healthy 4% sucrose
2 2 23 Male Tobacco chewer 4% sucrose
3 3 72 Female Oral Cancer 4% sucrose
4 4 24 Male Oral Cancer 4% sucrose
5 5 24 Male Smoker 4% sucrose
6 6 56 Male Healthy Listerine
7 7 26 Female Healthy Rexidine
8 8 23 Male Healthy Rexidine
9 10 50 Male Alcoholic Rexidine
10 11 65 Female Tobacco chewer Listerine
11 12 46 Female Tobacco chewer Listerine
12 13 67 Male Smoker 0.9% saline
13 14 70 Male Smoker 0.9% saline
14 15 38 Male Tobacco  chewer,  
Alcoholic and Smoker
Listerine 
15 16 36 Male Alcoholic Listerine
16 17 27 Female Stomach Cancer 0.9% saline
17 18 60 Female Oral Cancer 0.9% saline
18 19 60 Female Rectum Cancer 0.9% saline
19 21 76 Male Tobacco  chewer,  
Alcoholic & Smoker
Listerine
20 22 58 Male Smoker Listerine 
21 25 70 Female Tobacco chewer Listerine
22 26 63 Male Smoker. Alcoholic 0.9% saline
23 27 73 Female Tobacco chewer 0.9% saline
24 28 63 Male Smoker, Alcoholic 0.9% saline
25 29 65 Male Smoker 0.9% saline
Volunteers No.9, 20, 23, 24 ignored the study and did not provide sample.
TABLE   7.1
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Fig. No.  7.1. DNA smears.
DNA was extracted from buccal cells obtained from mouthwash samples and 
resuspended in approximately 0.5 ml of TE. One µl from each sample was run on a 
1% agarose gel stained with ethidium bromide.  The above figure showed the DNA 
smears of Volunteer no 2 and 3.  Volunteer no 2 was a tobacco   chewer and no.3 was 
a cancer patient. Lane no 5 and 6 shows smears of DNA. Lane 1 was loaded with 
DNA marker.  The band had migrated approximately to 21 bp which depicted that the 
DNA was of high molecular weight, but a smear over a broad size range was also 
observed.
High  molecular  weight  genomic  DNA  was  isolated  using  a  simple  non-
invasive method from buccal cells of 25 volunteers.  The present method yielded an 
average of 2µg DNA from the buccal cell samples, when the sample was collected in 
the  early  morning,  before  brushing  teeth,  transferred  at  room  temperature  to  the 
laboratory and processed within 3 hrs.  Human gene specific primer sequences were 
used in PCR amplifications and 1 DNA samples were amplified successfully.  
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A number of different protocols have been reported for extraction of DNA 
from  normal  healthy  individuals  in  case-control  studies.  Many  generally  observe 
reluctance on the part of healthy volunteers to donate blood, in such studies.  Also 
drawing blood from individuals requires a skilled technician, sterile needles, syringes, 
and controlled conditions for later processing when the donors might be suspected to 
be carriers for pathogenic viruses like hepatitis  and HIV.  Also transport of blood 
samples is often risky.  
Fig.No.  7.2 DNA from Buccal cells.
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This agarose gel electrophoresis showed a dull band of high molecular weight. 
Lane no 3 which belongs to a healthy volunteer no. 1.  Lane no. 1 is loaded with 
marker. 
Fig.No. 7.3 DNA from Buccal cells
Figure  7.3  showed  the  agarose  gel  electrophoresis  of  cancer  patients 
(volunteers no.17, 18, 19, Lane no 3, 4, 5, ) and one tobacco chewer (volunteer no. 21, 
Lane no 6).Lane 1 was loaded with DNA marker. A single high molecular weigh band 
denotes a good quality DNA.
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Fig. No. 7.4 DNA from buccal cells.
Figure 7.4 showed DNA smears  of (volunteers 8,10,15, 16, 22, ) which in this 
order corresponds to healthy, alcoholic, tobacco chewer, alcoholic, smoker, tobacco 
chewer, smoker, tobacco chewer, smoker & alcoholic and smoker. Lane no.3, 4,5,6,7 
showed dull smear  which indicates the presence of  DNA.
Fig.no. 7.5. DNA from mouthwash sample
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The bands of volunteers no 25, 26, 27, 28, 29 are shown in Lane 1, 2, 3, 4, 5. 
These bands are single which denotes the presence of good quality high molecular 
weight DNA.  The patients were tobacco chewer, smoker, tobacco chewer, smoker 
and a smoker.
Fig. No. 7.6 DNA from buccal cells
Figure 7.6 showed the band of (volunteers 4, 5, 6, 7) which corresponds to 
cancer, smoker, and 2 healthy patients. Lane no 3, 4, 5, 6 shows a pink dull band.
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Fig.No. 7.7 DNA from buccal cells.
Figure 7.7 showed agarose gel photos of (volunteers no 11, 12,13, 14) which 
corresponds to 2 tobacco chewers and 2 smokers.
                        Fig.No. 7.8. PCR results of 1 DNA sample amplified with IFN primers.
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PCR Photo of 1 DNA sample, in lane 2 is the parent DNA and in lane 3 is the 
amplified DNA. The samples no 17 was taken and amplified with IFN primers. 
S.No Absorbance 
at 260
Absorbance 
at 280
Absorbance 
ratio at 
260/280
YIELD 
in µg
1. 0.0357 0.0299 1.1 1.7
2. 0.0423 0.0382 1.1 2.1
3. 0.0431 0.0396 1.0 2.1
4. 0.0428 0.0382 1.1 2.1
5. 0.0452 0.0353 1.2 2.2
6. 0.0481 0.0254 1.8 2.4
7. 0.0357 0.0299 1.4 1.8
8. 0.0362 0.0237 1.5 1.8
9. 0.0372 0.0249 1.4 1.8
10. 0.0477 0.0251 1.7 2.3
11. 0.0376 0.0212 1.7 1.8
12. 0.0358 0.0214 1.6 1.7
13. 0.0368 0.0234 1.5 1.8
14. 0.0396 0.0295 1.6 1.9
15. 0.0512 0.0342 1.4 2.5
16. 0.0492 0.0384 1.2 2.4
17. 0.0276 0.0198 1.3 1.3
18. 0.0412 0.0301 1.3 2.0
19. 0.0394 0.0265 1.4 1.9
20. 0.0478 0.0363 1.3 2.3
21. 0.0399 0.0278 1.4 1.9
22. 0.0387 0.0278 1.3 1.9
23. 0.0422 0.0311 1.3 2.1
24. 0.0386 0.0276 1.3 1.9
25. 0.0543 0.0392 1.3 2.7
Table 7.2   Showed the purity ratio and the yield of DNA obtained.
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These results showed that buccal cell samples collected by mouthwash rinses 
and processed  under  optimal  conditions  can  be used for  genome-wide association 
studies with results  comparable to those obtained from DNA extracted from other 
alternatives.  Mean average of DNA obtained was 2µg and the individual amount is 
represented in table 7.2.  The mean value for 260/280 ratio was 1.3.
Although buccal cells  gave a smaller  amount of DNA than blood, recently 
developed methods of genotyping use very small amounts of DNA (2-10ng per assay) 
and thus allow the use of buccal cells as a source of DNA.  We did not evaluate the 
potential presence of bacterial DNA in these buccal samples.  
Comparison between mouthwashes and 
their purity ratio
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Fig. 7.9. Graphical representation of various mouthwashes used and their purity ratio 
at A260/280nm.
From the above figure it can be said that Listerine a commercial mouthwash 
which contains thymol, menthol, eucalyptus oil and alcohol 26%v/v, yielded the pure 
DNA with good yield and alcohol present in it reduced the microbial DNA presence. 
64
Next  went  Rexidine  which  was  also  a  commercial  mouthwash  containing 
chlorhexidine gluconate.  Even though, it yielded a moderate amount of DNA the dye 
was present in the supernatant in the last extraction which hindered the DNA isolation 
process and its purity.  0.9% saline was given to cancer patients and the yield and 
purity was average but bacterial contamination should be addressed.   The average 
purity obtained with this  solution was around 1.3 to 1.4. To the last went the 4% 
sucrose solution which gave purity around 1.1 and 1.2.  The purity ratio of DNA at 
A260/280nm should be around 1.8-2.0. Below this ratio the DNA is contaminated 
with protein and again should be extracted with phenol and chloroform.  As phenol 
and chloroform extraction method was used to isolate uncontaminated genomic DNA, 
without yeast sporule or bacteria, that could be stored for many years and can be used 
for DNA analysis.
Restriction fragment length polymorphism results
FIG. 7.9:  Agarose gel photo of RFLP.
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This  agarose  gel  photo  showed  the  fragments  generated  by  restriction 
endoculeases Eco RI and Hind III with samples 6 of a healthy volunteer (Listerine 
lane no. 4),   sample 12 of a tobacco chewer (Listerine lane no. 5)  and sample 18 of a  
cancer  patient  (0.9% saline  lane no.  6).  Lane 4 was loaded with DNA molecular 
Weight marker.
If the DNA of two individuals were cut with the same enzyme,  EcoR V for 
example,  two  patterns  of  DNA  fragments  are  produced,  making  it  possible  to 
distinguish them on the basis of the variation in the length of the fragments because 
each  pattern  of  fragments  is  unique  to  each  individual.  The  occurrence  of  many 
patterns of fragments with different lengths is called RFLP The relative position of 
bands, like a bar code, reveals the fragment sizes. The pattern of bands can then be 
used reliably to identify the individual source of the DNA.
In the above figure in Lane no.4 the band of normal patient when compared 
with a tobacco chewer in Lane no.5 there might have some mutation undergone in 
third fragment i.e., in approximately 6000 bp region.  1kb Marker was loaded to the 
Lane 3.
Lane no.5 also showed a difference at 8000 bp when compared with Lane 
no.4.  Lane No.6 shows some gap in the 2000bp region.   It was assumed that some 
variation i.e., polymorphism is present between the genes of normal, tobacco chewer 
and cancer patient.  Mutation may be a reason for such polymorphism.
RFLP was developed by Alec Jeffreys  in England, in the beginning of the 
1980s, this technique is based on the distance between restriction sites in the DNA.  
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Evaluation  of  exfoliated  cells  like  buccal  cells  or  bladder  epithelium is  an 
innovative  tool  for  genotoxicity  studies  which  is  very  promising  due  to  the  easy 
obtainment and handling24.  The results indicated that epithelial cells, could be a good 
biomarkers of early effects, and can be utilized for human monitoring, since in some 
cases, this kind of cell is the first to interact with xenobiotics. 
Fig.No.7.9a. A graphical representation.  Results are shown below.
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Fig.No.. 7.9b.  Graphical representation and results are shown below.
Fig.No.7.9c. Graphical representation, results shown below.
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Sample 1
      Band Volume Vol+BkGnd   Calib         Vol(ng)     AreaLane%      MW      Rf
      Posn
1     1          99          5254.95      47943.00     576.00      2.33        10263.16      0.30
2     2         118       11337.34      99370.00    1080.00     5.03          9334.74      0.36
3     3         131           646.81     18860.00      216.00      0.29         8291.61      0.40
4     4         142         6006.46    1512862.00   3168.00   15.98        7000.00       0.43
Sample 2
      Band Volume Vol+BkGnd   Calib       Vol(ng)   Area Lane%  MW    Rf
      posn
1    1      96         4100.34     32667.00   504.00   1.25      10421.05   0.29
2    2     112       38951.12  174933.00   1944.00   11.92       9652.57   0.34
3    3     139       35872.99    277395.00   2880.00   10.98       7385.21   0.42
4    4     180       11961.17  120600.00   1224.00   3.66       4236.70   0.54
5    5     202       26501.42  419195.00    4104.00    8.11       3508.58   0.61
6    6     259         8136.84  259528.00    2376.00    2.49        1775.00   0.78
7    7     291         1005.74  49184.00     432.00    0.31          975.00   0.88
Sample 3
Band Volume Vol+BkGnd  Calib         Vol(ng)    Area Lane%      MW       Rf 
            Posn
1 1  99 11569.50      112099.00    1224.00  4.34   10263.16      0.30
2 2 115 599.00            42817.00      504.00  0.22     9502.86      0.35
3 3 131 1521.00          57546.00      648.00   0.57     8291.61      0.40
4 4 153 13467.00      133091.00    1368.00      5.05     5536.02      0.46
5 5 172 1853.65          45931.00      504.00   0.69     4322.30      0.52
6 6 207 2005.20           40770.00     432.00      0.75     3183.76      0.63
7 7 286 28890.96        430202.00   3672.00  10.83     1100.00      0.86
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8. SUMMARY AND CONCLUSION
The basic  sequence  of  the  human  genome has  been completed  and in  the 
coming  years  a  majority  of  human  genes  will  be identified.   The next  step  is  to 
elucidate  the  differences  among  people  in  sequences,  genes,  and gene  expression 
patterns to explain what role these differences play in disease, and in some cases to 
develop genetic tests for these variants.  
We  found  that  total  DNA  yield  was  moderate  and  enough  for  PCR 
amplifications and RFLP.  Whole blood cells and buccal cells are commonly collected 
to obtain a DNA sample.  Processing of buccal cells from mouthwash samples is an 
attractive, non-invasive method for obtaining relatively large amounts of DNA.   Once 
DNA is collected, the genomic DNA must be isolated from other cellular material. 
Next, a specific region or unknown region must be identified or amplified, performed 
via PCR (RAPD).  Gel electrophoresis is often performed after PCR to verify that 
PCR  was  successful  and  that  the  amplified  target  sequence  is  the  correct  size. 
Numerous methods are available to determine a person’s genotype and differ based on 
allele  discrimination and detection.   PCR coupled with restriction fragment  length 
polymorphism (RFLP) analysis, a conventional genotyping method, does not rely on 
automated technology and is practical for laboratories that genotype a limited number 
of samples.  
The mouthwash method for obtaining DNA is simple, cost-effective and does 
not require elaborate instrumentation.  In addition, as repeated sampling is possible, 
there ought to be no paucity for using this DNA for various molecular biology tests, a 
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problem  commonly  encountered  when  working  with  peripheral  blood  samples. 
Genomic DNA in mouthwash is stable for prolonged periods at room temperature, 
and the  quantity  of  DNA recovered  from this  method  is  more  than  sufficient  for 
pharmacogenetic studies.
 As 4%sucrose, 0.9% saline and branded mouthwashes were used to collect the 
exfoliated cells, there should be no problem to the donor.
The RFLP performed would be useful  as a diagnosing tool when gone for 
Southern hybridization by using a probe.  The polymorphism was seen in the gel run 
and by sequencing the gene which has underwent mutation, can be screened out when 
sequenced or by using other advanced molecular techniques. In humans, RFLPs were 
first identified in the vicinity of the globing gene and have been used for diagnosing 
sickle cell anemia.  It can be also used for mapping genes and hence for characterizing 
genetic defects even if the gene in question is completely unknown28.
It can be concluded that mouthwash technique for obtaining DNA is a feasible 
and cost-effective method for large scale epidemiologic studies.  The DNA obtained 
from buccal cells could be utilized for genotyping, DNA finger printing and other 
genotyping assays.  RFLP study based upon comparison of band profile generated 
after  cutting  the  DNA  with  Restriction  enzymes  is  a  useful  tool  in  identifying 
polymorphism in individuals.   The study showed difference in DNA fragments  of 
Healthy, Tobacco users and Cancer patient generated after RFLP.  RAPD-PCR was 
successful with IFN primer sequence which was of human origin.  Hence it can be 
concluded that tobacco use in any form is injurious to health and might lead to cancer. 
Therefore Prevention is better than cure.
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